Arca
Skip to content
Tools
Tools

GP1BA: Platelet glycoprotein Ib alpha chain

GP-Ib, a surface membrane protein of platelets, participates in the formation of platelet plugs by binding to the A1 domain of vWF, which is already bound to the subendothelium.

  • Drugs that act on it: 1
  • Approved: 0
  • In phases 1 to 3: 1
  • Sponsors: 1

Who is on it, and how far along

Every drug ChEMBL records acting on GP1BA, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Protein or peptide 1

Approved0

    Phase 30

      Phase 21

      • Anfibatide

      Phase 10

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        DrugFurthest stageSponsorModalityActionOpen trials
        AnfibatidePhase 2Lee's PharmProtein or peptideAntagonistPlatelet glycoprotein Ib alpha chain antagonist1

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 1 in all, from ClinicalTrials.gov.
        TrialDrugPhaseStatusLead sponsorFirst posted
        Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Recombinant Anfibatide Injection in Healthy VolunteersAnfibatidePhase 1Not yet recruitingLee's Pharmaceutical LimitedOct 21, 2026

        Diseases most associated with it

        Open Targets association score, 0 to 1; all associations
        • Bernard-Soulier syndrome0.83
        • Platelet-type von Willebrand disease0.78
        • Hereditary optic neuropathy0.62
        • Macrothrombocytopenia0.48
        • Autosomal dominant macrothrombocytopenia0.39
        • Brooke-Spiegler syndrome0.37
        • Abnormal bleeding0.34
        • Impaired ristocetin-induced platelet aggregation0.27
        • Hereditary disease0.19
        • Mathematical ability0.19
        • Autoimmune thrombocytopenic purpura0.10

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL4630891, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-22. Gene name, function (UniProt P07359, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

        Esc

        Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

        Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.